- Chun-Jung Chang, .et al. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis, Biochem Pharmacol, 2021, Jan;183:114356 PMID: 33285108
Biological Activity
BIBF1120 (Vargatef) is a novel triple angiokinase inhibitor that inhibits three growth factor receptors simultaneously: VEGFR, PDGF and FGFR.
In vitro (25°C) | DMSO | 6 mg/mL (11.11 mM) | |
Water | Insoluble | ||
Ethanol | 3 mg/mL (5.55 mM) | ||
In vivo | 5% DMSO+40% PEG 300+2% Tween 80+ddH2O | 0.23 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 18.53 mL | 92.66 mL | 185.32 mL |
0.5 mM | 3.71 mL | 18.53 mL | 37.06 mL |
1 mM | 1.85 mL | 9.27 mL | 18.53 mL |
5 mM | 0.37 mL | 1.85 mL | 3.71 mL |
*The above data is based on the productmolecular weight 539.6 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Catalog Num | A10137 |
---|---|
Actions | Inhibitor |
CAS No. | 928326-83-4, 656247-17-5 |
Formula | C31H33N5O4 |
M. Wt | 539.6 |
Purity | >98% |
Synonyms | Bibf-1120, Nintedanib, Vargatef |
SMILES | CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N/C(=C\3/C4=C(C=C(C=C4)C(=O)OC)NC3=O)/C5=CC=CC=C5 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
Datasheet
Product Tags
Product Questions
Product Questions
No Questions
You may also be interested in the following product(s)
Regorafenib (BAY 73-4506)
Regorafenib (BAY 73-4506) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf. Regorafenib (BAY 73-4506) is an ora…
Taxifolin
Taxifolin is found to bind at the ATP-binding site on VEGFR-2 kinase with large value of binding energy and act as type I competitive inhibi…
E-7050 (Golvatinib)
E7050 (also known as golvatinib is an orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (v…
Tivozanib (AV-951)
Tivozanib (AV-951) is an oral VEGF receptor tyrosine kinase inhibitor that is designed to inhibit all three VEGF receptors.
E7080 (Lenvatinib)
E7080 is a multi-kinase inhibitor that inhibits both VEGFR2 and VEGFR3 kinases.
SKLB1002
SKLB1002 is a new potent VEGFR2 inhibitor, which could significantly inhibit HUVEC proliferation, migration, invasion, and tube formation.
XL647 (Tesevatinib)
XL647 is an orally bioavailable small-molecule RTK inhibitor that binds to and inhibits several tyrosine receptor kinases that play major ro…
ZM 306416
ZM 306416 is a VEGF receptor tyrosine kinase inhibitor that inhibits KDR (IC50 = 100 nM) and Flt (IC50 = 2 uM) tyrosine kinases.
Keywords:buy Bibf1120 (Nintedanib) | Bibf1120 (Nintedanib) Supplier | purchase | cost | manufacturer | order | distributor | buy 928326-83-4, 656247-17-5| 928326-83-4, 656247-17-5 Supplier | purchase 928326-83-4, 656247-17-5 | 928326-83-4, 656247-17-5 cost | 928326-83-4, 656247-17-5 manufacturer | order 928326-83-4, 656247-17-5 | 928326-83-4, 656247-17-5 distributor